Fig. 4.
Proportion of patients with cognitive impairment (score < 85) at baseline and after 1 and 2 years of natalizumab treatment in a GCS and b cognitive domains. GCS global cognitive score
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.